Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit
Whitehawk Therapeutics (Nasdaq: WHWK) announced that President and CEO Dave Lennon, PhD, will join a virtual fireside chat at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA on Wednesday, May 27, 2026, at 11:00 AM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Whitehawk Therapeutics (Nasdaq: WHWK) announced that President and CEO Dave Lennon, PhD, will join a virtual fireside chat at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA on Wednesday, May 27, 2026, at 11:00 AM ET.
A live webcast and 30-day replay will be available via the company’s investor relations website.
Details
News Market Reaction – WHWK
On May 20, the day this news came out, WHWK closed 3.69% above the previous close.
Data tracked by StockTitan Argus for the May 20 session.
Key Figures
- Conference edition
- 7th Annual
- TD Cowen Oncology Innovation Summit
- Event date
- May 27, 2026
- Scheduled fireside chat at TD Cowen summit
- Event time
- 11:00 AM ET
- Start time for virtual fireside chat
- Webcast replay period
- 30 days
- Replay availability after event
- Current price
- $4.07
- Prior to news release
- Daily change
- -4.24%
- 24h price change before article
- 52-week range
- $1.57–$5.495
- 52-week low and high
- 200-day MA
- $2.74
- Technical trend indicator, price trading above
Historical Context
-
Announcement of Stifel virtual targeted oncology forum fireside chat.
-
Approximately $87.5M private placement to fund ADC pipeline and operations.
-
Q1 2026 loss, higher R&D, no revenue, but strong cash runway into 2028.
-
AACR 2026 preclinical ADC data showing tumor regressions and tolerability.
-
Jones Trading Post-AACR fireside chat with webcast access and replay.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
antibody drug conjugate medical
adc medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast of the event can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.
About Whitehawk Therapeutics
Whitehawk Therapeutics is a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available at www.whitehawktx.com and connect with us on LinkedIn.
Contact:
IR@whitehawktx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-the-td-cowen-7th-annual-oncology-innovation-summit-302777476.html
SOURCE Whitehawk Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.